The Valley Desk

ArticleObesity science & practicePublished

Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Obesity science & practice
Published
Subject terms
Obesity; Pharmacotherapy; Predictors; Medication Adherence; Treatment Targets; Fixed‐dose Extended‐release Combination Of Naltrexone And Bupropion
PubMed ID
42311561
PubMed Central ID
PMC13270069
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal